Skip to main content

NeuroPace, Inc. (NPCE)

NASDAQ: NPCE · IEX Real-Time Price · USD
17.42
0.00 (-0.01%)
After-hours:Sep 17, 2021 4:04 PM EDT
17.42
-0.33 (-1.86%)
At close: Sep 17, 4:00 PM
Market Cap427.37M
Revenue (ttm)47.37M
Net Income (ttm)n/a
Shares Out17.55M
EPS (ttm)-5.26
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume126,682
Open17.68
Previous Close17.75
Day's Range16.99 - 17.79
52-Week Range16.99 - 27.38
Betan/a
Analystsn/a
Price Target27.50 (+57.9%)
Est. Earnings DateNov 11, 2021

About NPCE

NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Our novel and differentiated RNS System is the first and only commercially available, brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source. By continuously monitoring the brain’s electrical activity, recognizing patient-specific abnormal electrical patterns, and responding in real time with impercep...

IndustryMedical Devices
IPO DateApr 22, 2021
CEOMichael Favet
Employees159
Stock ExchangeNASDAQ
Ticker SymbolNPCE
Full Company Profile

Financial Performance

In 2020, NeuroPace's revenue was $41.14 million, an increase of 11.27% compared to the previous year's $36.97 million. Losses were -$24.28 million, -19.00% less than in 2019.

Financial Statements

News

NeuroPace to Participate in Upcoming Conferences

MOUNTAIN VIEW, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, to...

3 weeks ago - GlobeNewsWire

NeuroPace Reports Second Quarter 2021 Financial Results

MOUNTAIN VIEW, Calif. , Aug. 12, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, t...

1 month ago - GlobeNewsWire

NeuroPace Launches nSight Platform and Partnership with Seizure Tracker™ to Provide Doctors With Personalized Informa...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc. (NASDAQ: NPCE), a medical technology company dedicated to transforming the lives of people suffering from epilepsy, today announced the broad laun...

1 month ago - Business Wire

NeuroPace To Report Second Quarter 2021 Financial Results on August 12, 2021

MOUNTAIN VIEW, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, to...

1 month ago - GlobeNewsWire

Could This Recently IPOed Medical Device Maker Make You Rich?

Small-cap epilepsy treatment specialist NeuroPace looks a lot like Abiomed did in its early days.

Other symbols:ABMD
2 months ago - The Motley Fool

NeuroPace Awarded Five-Year NIH Grant Funding of More than $9M to Study RNS System in Patients with Lennox-Gastaut Sy...

Feasibility IDE study will be the first to evaluate responsive neuromodulation for a severe and disabling childhood-onset epilepsy

2 months ago - GlobeNewsWire

NeuroPace Reports First Quarter 2021 Financial Results and Provides 2021 Financial Guidance

MOUNTAIN VIEW, Calif., June 03, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, to...

3 months ago - GlobeNewsWire

NeuroPace To Report First Quarter 2021 Financial Results on June 3, 2021

MOUNTAIN VIEW, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, tod...

3 months ago - GlobeNewsWire

NeuroPace, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchas...

MOUNTAIN VIEW, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on developing products to treat and transform the lives of pat...

4 months ago - GlobeNewsWire

NeuroPace, Inc. Announces Pricing of Initial Public Offering

MOUNTAIN VIEW, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on developing products to treat and transform the lives of pat...

4 months ago - GlobeNewsWire

Let's Take a Look At Some Upcoming IPOs This Week

There have been quite a few appealing Initial Public Offerings (IPOs) available on the market so far this year. Here are some upcoming IPOs that investors should be watching out for.

Other symbols:PATHSKYTSWIMZY
4 months ago - Benzinga

NeuroPace IPO Registration Document (S-1)

NeuroPace, Inc. has filed to go public with an IPO on the NASDAQ.

5 months ago - SEC